Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Ultragenyx Pharmaceutical
RARE
$2.6B
| $70.1M | 0.02% |
506,510
+57,123
| +13% | +$6.78M |
|
702
PUT
Occidental Petroleum
OXY
$57.7B
| $70M | 0.02% |
4,044,764
+87,964
| +2% | +$1.21M |
|
703
eBay
EBAY
$46.5B
| $70M | 0.02% |
1,393,305
+931,616
| +202% | +$47.6M |
|
704
Salesforce
CRM
$165B
| $70M | 0.02% |
314,439
-1,106,916
| -78% | -$269M |
|
705
CALL
Palantir
PLTR
$430B
| $69.9M | 0.02% |
+2,968,200
| New | +$53.1M |
|
706
D.R. Horton
DHI
$41.9B
| $69.9M | 0.02% |
+1,013,745
| New | +$73.9M |
|
707
PUT
Medtronic
MDT
$116B
| $69.6M | 0.02% |
594,400
-16,100
| -3% | -$1.77M |
|
708
CALL
CME Group
CME
$96.1B
| $69.4M | 0.02% |
381,300
+3,200
| +0.8% | +$544K |
|
|
DISH
709
DELISTED
DISH Network Corp.
DISH
| $69M | 0.02% |
2,133,233
+1,203,383
| +129% | +$37M |
|
710
Olema Pharmaceuticals
OLMA
$920M
| $69M | 0.02% |
+1,434,796
| New | +$67.3M |
|
711
CALL
Arista Networks
ANET
$257B
| $68.9M | 0.02% |
3,792,000
-49,600
| -1% | -$786K |
|
712
Wyndham Hotels & Resorts
WH
$5.51B
| $68.9M | 0.02% |
1,158,379
-552,361
| -32% | -$29.8M |
|
713
CALL
United States Oil Fund
USO
$1.77B
| $68.7M | 0.02% |
2,081,880
-5,520
| -0.3% | -$164K |
|
714
Acadia Pharmaceuticals
ACAD
$4.89B
| $68.1M | 0.02% |
1,273,029
-1,296,722
| -50% | -$64.4M |
|
|
X
715
PUT
DELISTED
US Steel
X
| $67.9M | 0.02% |
4,046,300
+2,005,800
| +98% | +$24.9M |
|
716
PUT
Clorox
CLX
$12.9B
| $67.8M | 0.02% |
335,900
-175,200
| -34% | -$36.3M |
|
717
CALL
Sarepta Therapeutics
SRPT
$1.95B
| $67.8M | 0.02% |
397,800
+177,900
| +81% | +$26.4M |
|
|
PXD
718
DELISTED
Pioneer Natural Resource Co.
PXD
| $67.7M | 0.02% |
594,817
+468,665
| +372% | +$45.6M |
|
719
PUT
Darden Restaurants
DRI
$25.4B
| $67.5M | 0.02% |
566,900
+228,500
| +68% | +$24.5M |
|
720
PUT
PENN Entertainment
PENN
$2.53B
| $67.5M | 0.02% |
781,800
-1,065,200
| -58% | -$76M |
|
721
Illumina
ILMN
$29.1B
| $67.3M | 0.02% |
186,999
+12,349
| +7% | +$3.94M |
|
722
LyondellBasell Industries
LYB
$20.2B
| $66.6M | 0.02% |
727,051
+578,603
| +390% | +$47.1M |
|
723
PUT
Danaher
DHR
$143B
| $66.6M | 0.02% |
337,949
+211,275
| +167% | +$42.4M |
|
724
PUT
Philip Morris
PM
$294B
| $66.5M | 0.02% |
803,700
+53,300
| +7% | +$4.15M |
|
|
X
725
CALL
DELISTED
US Steel
X
| $66.5M | 0.02% |
3,966,000
+1,244,700
| +46% | +$15.5M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.